From Comorbidities of Chronic Obstructive Pulmonary Disease to Identification of Shared Molecular Mechanisms by Data Integration

Authors: D. Gomez-Cabrero, J. Menche, C. Vargas, I. Cano, D. Maier, A.-L. Barabasi, J. Tegner, J. Roca (Synergy-COPD Consortia)

Publication Date: November 22, 2016

Journal: BMC Bioinformatics 17: 1291 (2016)

Background Deep mining of healthcare data has provided maps of comorbidity relationships between diseases. In parallel, integrative multi-omics investigations have generated high-resolution molecular maps of putative relevance for understanding disease initiation and progression. Yet, it is unclear how to advance an observation of comorbidity relations (one disease to others) to a molecular understanding of the driver processes and associated biomarkers. Results Since Chronic Obstructive Pulmonary disease (COPD) has emerged as a central hub in temporal comorbidity networks, we developed a systematic integrative data-driven framework to identify shared disease-associated genes and pathways, as a proxy for the underlying generative mechanisms inducing comorbidity. We integrated records from approximately 13 M patients from the Medicare database with disease-gene maps that we derived from several resources including a semantic-derived knowledge-base. Using rank-based statistics we not only recovered known comorbidities but also discovered a novel association between COPD and digestive diseases. Furthermore, our analysis provides the first set of COPD co-morbidity candidate biomarkers, including IL15, TNF and JUP, and characterizes their association to aging and life-style conditions, such as smoking and physical activity. Conclusions The developed framework provides novel insights in COPD and especially COPD co-morbidity associated mechanisms. The methodology could be used to discover and decipher the molecular underpinning of other comorbidity relationships and furthermore, allow the identification of candidate co-morbidity biomarkers.

ezgif.com-webp-to-png (5).png
Previous
Previous

Network-based approach to prediction and population-based validation of in silico drug repurposing

Next
Next

Endophenotype Network Models: Common Core of Complex Diseases